产品编号 :
Cas No. :
CAS No. |
1807988-02-8 |
|---|---|
中文名称 |
(2R,5S,13aR)-8-羟基-7,9-二氧代-N-(2,4,6-三氟苄基)-2,3,4,5,7,9,13,13a-八氢-2,5-甲桥吡啶并[1',2':4,5]吡嗪并[2,1-b][1,3]氧氮杂䓬-10-甲酰胺钠盐 |
英文名称 |
(2R,5S,13aR)-8-Hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide sodium salt |
别名 |
A904622 | NCGC00159452-05 | 1807988-02-8 | BICTEGRAVIR SODIUM [WHO-DD] | GS-9883; GS 9883; GS9883; GS-9883-01; GS9883-01; GS 9883-01 | WJNFBIVCQMPPJC-FQYDJHLKSA-M | GS-9883 sodium | CS-0380750 | SCHEMBL19991461 | BICTEGRAVIR SODIUM COMPONENT OF BIKTARVY | |
标准英文名 |
sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate |
分子式 |
C21H17F3N3NaO5 |
分子量 |
471.37 |
精确分子量 |
471.10 |
SMILES |
[H][C@]12CC[C@@]([H])(O[C@]3(N2C(C(N4C3)=C(C(C(C(NCC5=C(C=C(C=C5F)F)F)=O)=C4)=O)[O-])=O)[H])C1.[Na+] |
标准SMILES |
[Na+].[O-]C1=C2C(=O)N3[C@@H](CN2C=C(C(=O)NCC2C(F)=CC(F)=CC=2F)C1=O)O[C@H]1C[C@@H]3CC1 |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Danger |
InChIKey |
WJNFBIVCQMPPJC-FQYDJHLKSA-M |
危险类别(旧) |
H318,H410 |
存储要求 |
Keep in dark place, inert atmosphere, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Serious eye damage/eye irritation (Category 1),Hazardous to the aquatic environment, long-term hazard (Category 1) |
|---|---|
UN No. |
3077,3077,3077 |
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|